← Leaderboards
Colin K Ohrt
Glaxosmithkline
$26,000
Attributed
$26,000
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$26,000 · 1
By mechanism
RC1$26,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Glaxosmithkline
Same institution · by research overlap
- John T Lonsdale$9,325,244
- Brian Wynne$7,031,061
- Ken Duncan$1,211,279
- Jonathan R Seals$3,489,073
Others in their field
Top investigators on “Africa”
- Wafaa M. El-Sadr · Columbia University Health Sciences$372,070,023
- Myron S Cohen · Family Health International$371,035,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$169,486,689
- Carol Nesel · Westat$157,229,158
- Constance Ann Benson · University Of California, San Diego$156,911,346
- Sten H Vermund · University Of Alabama At Birmingham$130,129,209
Research focus
AfricaAntimalarial AgentsBritish IslesClinical ResearchDrug Design /Synthesis /ProductionDrug Screening /EvaluationHuman SubjectMalariaPlasmodium FalciparumSoutheast Asia